FIGURE

Fig. 2

ID
ZDB-FIG-250528-2
Publication
Chen et al., 2025 - The combination of midkine inhibitor with Lenvatinib amplifies the suppression of hepatocellular carcinoma
Other Figures
All Figure Page
Back to All Figure Page
Fig. 2

The expression levels of MDK in different HCC cell lines. (A) MDK expression at the mRNA level in normal hepatocytes 7701, hepatic stellate cells LX-2, and several HCC cell lines (Hep3B, HepG2, Huh7, MHCC-97 L, MHCC-97H). (B) Midkine protein levels were assessed in normal hepatocytes (7701), hepatic stellate cells (LX-2), and various HCC cell lines (Hep3B, HepG2, Huh7, MHCC-97 L, MHCC-97H). The grey values of the strips were quantified using ImageJ 2 software, defining the average grey value of hepatocyte 7701 as 1. Compare the significance of the difference between each group and 7701 using Student's t-test. Probability values p < .05 denote statistical differences, with statistical significance indicated by “*” for p < .05 and “**” for p < .01. Three independent replicate experiments were performed, four replicates per experiment for RT-qPCR and three replicate measurements per replicate for WB experiments. The results of quantification are presented as the mean ± SD.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ IUBMB Life